{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:48:17Z","timestamp":1787096897466,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Provincial College Students Innovation Training Program of Central South University","award":["S2021105330737"],"award-info":[{"award-number":["S2021105330737"]}]},{"name":"Changsha Science and Technology Bureau Scientific Research Project","award":["Kq2004155"],"award-info":[{"award-number":["Kq2004155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>TIMM8A is a protein-coding gene located on the X chromosome. There is evidence that TIMM8A plays an important role in mitochondrial morphology and fission. Studies have shown that mitophagy and fission could affect the function of immune cells. However, there is currently no research on this gene\u2019s role in cancer occurrence and progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>TIMM8A expression was analyzed via the Tumor Immune Estimation Resource (TIMER) site and UALCAN database. We evaluated the influence of TIMM8A on clinical prognosis using Kaplan-Meier plotter, the PrognoScan database, and Human Protein Atlas (HPA). The correlations between TIMM8A and cancer immune infiltrates were investigated via TIMER. Tumor Immune Dysfunction and Exclusion (TIDE) was used to evaluate the potential of tumor immune evasion. Functions of TIMM8A mutations and 50 genes significantly associated with TIMM8A mutations in breast cancer (BRCA) and uterine corpus endometrial cancer (UCEC) were analyzed by GO and KEGG in LinkedOmics database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We investigated the role of TIMM8A in multiple cancers and found that it was significantly associated with poor prognosis in BRCA and UCEC. After analyzing the effect of TIMM8A on immune infiltration, we found Th2 CD4+ T cells might be a common pathway by which TIMM8A contributed to poor prognosis in BRCA and UCEC. Our results suggested that myeloid-derived suppressor cells (MDSC) and tumor-associated M2 macrophages (TAM M2) might be important factors in immune evasion through T cell rejection in both cancers, and considered TIMM8A as a biomarker to predict the efficacy of this therapy in BRCA and UCEC. The results of TIMM8A enrichment analysis showed us that abnormally expressed TIMM8A might affect the mitochondrial protein in BRCA and UCEC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Contributed to illustrating the value of TIMM8A as a prognostic biomarker, our findings suggested that TIMM8A was correlated with prognosis and immune infiltration, including CD8+ T cells, Th2 CD4+ T cells, and macrophages in BRCA and UCEC. In addition, TIMM8A might affect immune infiltration and prognosis in BRCA and UCEC by affecting mitophagy. We believed it could also be a biomarker to predict the efficacy of anti-PD-L1 therapy and proposed to improve the efficacy by eliminating MDSC and TAM M2.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02736-6","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T08:04:15Z","timestamp":1665129855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaoyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zile","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"2736_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2736_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-20301-6_1","volume":"1152","author":"A Ahmad","year":"2019","unstructured":"Ahmad A. Breast cancer statistics: recent trends. Adv Exp Med Biol. 2019;1152:1\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"2736_CR3","first-page":"405","volume":"90","author":"G Trojano","year":"2019","unstructured":"Trojano G, Olivieri C, Tinelli R, Damiani GR, Pellegrino A, Cicinelli E. Conservative treatment in early stage endometrial cancer: a review. Acta Biomed. 2019;90:405\u201310.","journal-title":"Acta Biomed"},{"key":"2736_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12885-018-4441-3","volume":"18","author":"JP Bates","year":"2018","unstructured":"Bates JP, Derakhshandeh R, Jones L, Webb TJ. Mechanisms of immune evasion in breast cancer. BMC Cancer. 2018;18:556.","journal-title":"BMC Cancer"},{"key":"2736_CR5","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121:3609\u201322.","journal-title":"J Clin Invest"},{"key":"2736_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10147-019-01437-7","volume":"24","author":"F De Felice","year":"2019","unstructured":"De Felice F, Marchetti C, Tombolini V, Panici PB. Immune check-point in endometrial cancer. Int J Clin Oncol. 2019;24:910\u20136.","journal-title":"Int J Clin Oncol"},{"key":"2736_CR7","doi-asserted-by":"publisher","unstructured":"van den Bulk J, Verdegaal EM, de Miranda NF. Cancer immunotherapy: broadening the scope of targetable tumours. Open Biol. 2018. https:\/\/doi.org\/10.1098\/rsob.180037.","DOI":"10.1098\/rsob.180037"},{"key":"2736_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000464353","volume":"40","author":"F Schutz","year":"2017","unstructured":"Schutz F, Stefanovic S, Mayer L, von Au A, Domschke C, Sohn C. PD-1\/PD-L1 pathway in breast cancer. Oncol Res Treat. 2017;40:294\u20137.","journal-title":"Oncol Res Treat"},{"key":"2736_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","volume":"5","author":"LA Emens","year":"2019","unstructured":"Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, et al. Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study. JAMA Oncol. 2019;5:74\u201382.","journal-title":"JAMA Oncol"},{"key":"2736_CR10","first-page":"1","volume":"40","author":"AK Green","year":"2020","unstructured":"Green AK, Feinberg J, Makker V. A review of immune checkpoint blockade therapy in endometrial cancer. Am Soc Clin Oncol Educ Book. 2020;40:1\u20137.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2736_CR11","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","volume":"125","author":"Y Yang","year":"2015","unstructured":"Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125:3335\u20137.","journal-title":"J Clin Invest"},{"key":"2736_CR12","first-page":"2030","volume":"54","author":"Y Nakayama","year":"2019","unstructured":"Nakayama Y, Mimura K, Tamaki T, Shiraishi K, Kua LF, Koh V, et al. PhosphoSTAT1 expression as a potential biomarker for antiPD1\/antiPDL1 immunotherapy for breast cancer. Int J Oncol. 2019;54:2030\u20138.","journal-title":"Int J Oncol"},{"key":"2736_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1121","volume":"8","author":"A Neighbors","year":"2020","unstructured":"Neighbors A, Moss T, Holloway L, Yu SH, Annese F, Skinner S, et al. Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome. Mol Genet Genomic Med. 2020;8:e1121.","journal-title":"Mol Genet Genomic Med"},{"key":"2736_CR14","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/brain\/awg174","volume":"126","author":"J Binder","year":"2003","unstructured":"Binder J, Hofmann S, Kreisel S, Wohrle JC, Bazner H, Krauss JK, et al. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. Brain. 2003;126:1814\u201320.","journal-title":"Brain"},{"key":"2736_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/hmg\/ddr458","volume":"21","author":"G Engl","year":"2012","unstructured":"Engl G, Florian S, Tranebjaerg L, Rapaport D. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology. Hum Mol Genet. 2012;21:287\u201399.","journal-title":"Hum Mol Genet"},{"key":"2736_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","volume":"16","author":"Y Xu","year":"2020","unstructured":"Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy. 2020;16:3\u201317.","journal-title":"Autophagy"},{"key":"2736_CR17","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108\u201310.","journal-title":"Cancer Res"},{"key":"2736_CR18","first-page":"18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genet. 2009;2:18.","journal-title":"BMC Med Genet"},{"key":"2736_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10549-016-4013-7","volume":"160","author":"A Lanczky","year":"2016","unstructured":"Lanczky A, Nagy A, Bottai G, Munkacsy G, Szabo A, Santarpia L, et al. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 2016;160:439\u201346.","journal-title":"Breast Cancer Res Treat"},{"key":"2736_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Neoplasia"},{"key":"2736_CR21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138.","journal-title":"Nat Med"},{"key":"2736_CR22","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u201363.","journal-title":"Nucleic Acids Res"},{"key":"2736_CR23","doi-asserted-by":"publisher","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015. https:\/\/doi.org\/10.1126\/science.1260419.","DOI":"10.1126\/science.1260419"},{"key":"2736_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2407-7-59","volume":"7","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, et al. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer. 2007;7:59.","journal-title":"BMC Cancer"},{"key":"2736_CR25","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1186\/bcr2120","volume":"10","author":"C Yau","year":"2008","unstructured":"Yau C, Benz CC. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res. 2008;10:R61.","journal-title":"Breast Cancer Res"},{"key":"2736_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005\u20139.","journal-title":"Nature"},{"key":"2736_CR27","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1158\/0008-5472.CAN-07-5206","volume":"68","author":"M Schmidt","year":"2008","unstructured":"Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68:5405\u201313.","journal-title":"Cancer Res"},{"key":"2736_CR28","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.4161\/15384101.2014.954454","volume":"13","author":"C Cadenas","year":"2014","unstructured":"Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R, et al. Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014;13:3282\u201391.","journal-title":"Cell Cycle"},{"key":"2736_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2105-11-276","volume":"11","author":"B Hellwig","year":"2010","unstructured":"Hellwig B, Hengstler JG, Schmidt M, Gehrmann MC, Schormann W, Rahnenfuhrer J. Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes. BMC Bioinformatics. 2010;11:276.","journal-title":"BMC Bioinformatics"},{"key":"2736_CR30","doi-asserted-by":"publisher","unstructured":"Heimes AS, Hartner F, Almstedt K, Krajnak S, Lebrecht A, Battista MJ, et al. Prognostic significance of interferon-gamma and its signaling pathway in early breast cancer depends on the molecular subtypes. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21197178.","DOI":"10.3390\/ijms21197178"},{"key":"2736_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S1470-2045(20)30156-X","volume":"21","author":"MS Lee","year":"2020","unstructured":"Lee MS, Ryoo BY, Hsu CH, Numata K, Stein S, Verret W, et al. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Lancet Oncol. 2020;21:808\u201320.","journal-title":"Lancet Oncol"},{"key":"2736_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","volume":"33","author":"A Eiyama","year":"2015","unstructured":"Eiyama A, Okamoto K. PINK1\/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol. 2015;33:95\u2013101.","journal-title":"Curr Opin Cell Biol"},{"key":"2736_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semcdb.2019.05.029","volume":"98","author":"F Ferro","year":"2020","unstructured":"Ferro F, Servais S, Besson P, Roger S, Dumas JF, Brisson L. Autophagy and mitophagy in cancer metabolic remodelling. Semin Cell Dev Biol. 2020;98:129\u201338.","journal-title":"Semin Cell Dev Biol"},{"key":"2736_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/intimm\/13.4.459","volume":"13","author":"MJ Smyth","year":"2001","unstructured":"Smyth MJ, Crowe NY, Godfrey DI. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol. 2001;13:459\u201363.","journal-title":"Int Immunol"},{"key":"2736_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri1936","volume":"6","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6:715\u201327.","journal-title":"Nat Rev Immunol"},{"key":"2736_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00262-003-0443-2","volume":"53","author":"P Serafini","year":"2004","unstructured":"Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, et al. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother. 2004;53:64\u201372.","journal-title":"Cancer Immunol Immunother"},{"key":"2736_CR37","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","volume":"166","author":"DI Gabrilovich","year":"2001","unstructured":"Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 2001;166:5398\u2013406.","journal-title":"J Immunol"},{"key":"2736_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1073\/pnas.0408197102","volume":"102","author":"ML Chen","year":"2005","unstructured":"Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A. 2005;102:419\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2736_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","volume":"222","author":"M Johansson","year":"2008","unstructured":"Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev. 2008;222:145\u201354.","journal-title":"Immunol Rev"},{"key":"2736_CR40","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1158\/0008-5472.CAN-14-3590","volume":"75","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Qin J, Zhong L, Gong L, Zhang B, Zhang Y, et al. CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer. Cancer Res. 2015;75:4312\u201321.","journal-title":"Cancer Res"},{"key":"2736_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781087","volume":"12","author":"ZY Zhu","year":"2021","unstructured":"Zhu ZY, Tang N, Wang MF, Zhou JC, Wang JL, Ren HZ, et al. Comprehensive pan-cancer genomic analysis reveals PHF19 as a carcinogenic indicator related to immune infiltration and prognosis of hepatocellular carcinoma. Front Immunol. 2021;12:781087.","journal-title":"Front Immunol"},{"key":"2736_CR42","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234:8509\u201321.","journal-title":"J Cell Physiol"},{"key":"2736_CR43","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.7150\/thno.52435","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Gao A, Zhang F, Yang Z, Wang S, Fang Y, et al. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics. 2021;11:3392\u2013416.","journal-title":"Theranostics"},{"key":"2736_CR44","doi-asserted-by":"publisher","first-page":"117955492110355","DOI":"10.1177\/11795549211035540","volume":"15","author":"T Li","year":"2021","unstructured":"Li T, Liu T, Zhu W, Xie S, Zhao Z, Feng B, et al. Targeting MDSC for immune-checkpoint blockade in cancer immunotherapy: current progress and new prospects. Clin Med Insights Oncol. 2021;15:11795549211035540.","journal-title":"Clin Med Insights Oncol"},{"key":"2736_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/hmg\/11.5.477","volume":"11","author":"K Roesch","year":"2002","unstructured":"Roesch K, Curran SP, Tranebjaerg L, Koehler CM. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1\/TIMM8a-TIMM13 complex. Hum Mol Genet. 2002;11:477\u201386.","journal-title":"Hum Mol Genet"},{"key":"2736_CR46","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene. 2013;32:4814\u201324.","journal-title":"Oncogene"},{"key":"2736_CR47","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/or.2014.3690","volume":"33","author":"A Cormio","year":"2015","unstructured":"Cormio A, Cormio G, Musicco C, Sardanelli AM, Gasparre G, Gadaleta MN. Mitochondrial changes in endometrial carcinoma: possible role in tumor diagnosis and prognosis (review). Oncol Rep. 2015;33:1011\u20138.","journal-title":"Oncol Rep"},{"key":"2736_CR48","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng X, Qian Y, Fu B, Jiao D, Jiang Y, Chen P, et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat Immunol. 2019;20:1656\u201367.","journal-title":"Nat Immunol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02736-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T09:07:20Z","timestamp":1665133640000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02736-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02736-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"16 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}